Literature DB >> 16573375

Case-control analysis of dietary folate and risk of bladder cancer.

Matthew B Schabath1, Margaret R Spitz, Seth P Lerner, Patricia C Pillow, Ladia M Hernandez, George L Delclos, H Barton Grossman, Xifeng Wu.   

Abstract

Dietary folate, a water-soluble B vitamin found in a variety of fruits and vegetables, is of particular interest as a chemopreventive agent due to its role in DNA methylation and DNA synthesis and repair. We hypothesized that individuals with low folate intake would be at an increased risk for bladder cancer. Using an ongoing case-control study we assessed dietary folate in 409 incident bladder cancer patients and 451 healthy control subjects. A food-frequency questionnaire was used to estimate naturally occurring food folate (microg/kcal/day), dietary folate equivalents (DFE) from food sources (microg DFE/kcal/day), and DFE from all sources (microg DFE/kcal/day). Unconditional logistic regression analyses were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Bladder cancer patients reported a statistically significant lower intake of folate than control subjects for food folate and DFE from food sources (P < 0.001) but not for DFE from all sources (P = 0.061). In the highest quartile of food folate intake there was a 54% reduced risk for bladder cancer (OR = 0.46; 95% CI = 0.29-0.73) after adjusting for age, gender, ethnicity, smoking, and total energy intake. Similarly, the highest quartile of intake was associated with a 59% reduced risk for DFE from food sources (OR = 0.41; 95% CI = 0.26-0.65) and a 35% reduced risk for DFE from all sources (OR = 0.65; 95% CI = 0.42-1.00). In the joint-effects analyses using never smokers with high folate intake as the reference group (OR = 1.0), heavy smokers with low food folate intake had a 2.31-fold (95% CI = 1.11-4.82) increased risk, whereas heavy smokers with high folate intake had a reduced OR of 1.31 (95% CI = 0.53-3.26). Although the ORs were not statistically significant, light smokers and high folate intake exhibited a protective effect (OR = 0.62; 95% CI = 0.20-1.94), whereas an increased risk was observed for light smoking and low folate intake (OR = 1.41; 95% CI = 0.57-3.45). These patterns were consistent for the joint effects of smoking and DFE from food sources and DFE from all sources. In summary, high intake of dietary folate was associated with an overall decrease in bladder cancer risk. These data may have important implications for cancer prevention; however, large, hypothesis-driven, population-based clinical trials will be required to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16573375     DOI: 10.1207/s15327914nc5302_3

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  7 in total

1.  The association between methylene-tetrahydrofolate reductase gene polymorphism and lung cancer risk.

Authors:  Sulhattin Arslan; Sule Karadayi; Malik Ejder Yildirim; Ozturk Ozdemir; Ibrahim Akkurt
Journal:  Mol Biol Rep       Date:  2010-06-08       Impact factor: 2.316

2.  Invited commentary: Preventing neural tube defects and more via food fortification?

Authors:  James L Mills; Tonia C Carter
Journal:  Am J Epidemiol       Date:  2008-10-25       Impact factor: 4.897

Review 3.  [Primary prevention of bladder cancer. What's new?].

Authors:  J E Altwein
Journal:  Urologe A       Date:  2007-06       Impact factor: 0.639

4.  Expression of RFC/SLC19A1 is associated with tumor type in bladder cancer patients.

Authors:  Alyaa M Abdel-Haleem; Maha I El-Zeiry; Laila G Mahran; Khaled Abou-Aisha; Mona H Rady; Jan Rohde; Marwa Mostageer; Hilde Spahn-Langguth
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

5.  One-carbon metabolism biomarkers and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition.

Authors:  Alina Vrieling; H Bas Bueno-De-Mesquita; Martine M Ros; Ellen Kampman; Katja K Aben; Frederike L Büchner; Eugène H Jansen; Nina Roswall; Anne Tjønneland; Marie-Christine Boutron-Ruault; Claire Cadeau; Jenny Chang-Claude; Rudolf Kaaks; Steffen Weikert; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Sabina Sieri; Domenico Palli; Salvatore Panico; Petra H Peeters; Elisabete Weiderpass; Guri Skeie; Paula Jakszyn; María-Dolores Chirlaque; Eva Ardanaz; María-José Sánchez; Roy Ehrnström; Johan Malm; Börje Ljungberg; Kay-Tee Khaw; Nick J Wareham; Paul Brennan; Mattias Johansson; Elio Riboli; Lambertus A Kiemeney
Journal:  Int J Cancer       Date:  2019-02-13       Impact factor: 7.396

6.  Dietary B group vitamin intake and the bladder cancer risk: a pooled analysis of prospective cohort studies.

Authors:  Iris W A Boot; Anke Wesselius; Evan Y W Yu; Maree Brinkman; Piet van den Brandt; Eric J Grant; Emily White; Elisabete Weiderpass; Pietro Ferrari; Matthias B Schulze; Bas Bueno-de-Mesquita; Maria Jose-Sanchez; Bjorn Gylling; Maurice P Zeegers
Journal:  Eur J Nutr       Date:  2022-02-07       Impact factor: 4.865

7.  Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study.

Authors:  Maree T Brinkman; Margaret R Karagas; Michael Scott Zens; Alan Schned; Raoul C Reulen; Maurice P Zeegers
Journal:  Cancer Causes Control       Date:  2009-12-31       Impact factor: 2.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.